Research on infectious diseases requires better coordination
- 1 December 2004
- journal article
- Published by Springer Nature in Nature Medicine
- Vol. 10 (S12) , S137-S140
- https://doi.org/10.1038/nm1153
Abstract
This special supplement of Nature Medicine, directed at the topic of emerging infectious diseases, is very timely. Recent high-profile outbreaks have highlighted the global risk that infectious agents, both new and old, represent for society. The experience of severe acute respiratory syndrome (SARS) shows the risk posed by emerging infectious diseases, but also the power of strongly coordinated global surveillance and public health measures, coupled with scientific research, to keep infection under control1,2. Diseases such as drug-resistant malaria continue to be threats. There is a need to enhance global resources to investigate, detect and respond to emerging infections, and to appropriately coordinate and direct research efforts to meet the challenges presented by these diseases.Keywords
This publication has 21 references indexed in Scilit:
- Taking the sting out of the anthrax vaccineJournal of Clinical Investigation, 2004
- The international response to the outbreak of SARS in 2003Philosophical Transactions Of The Royal Society B-Biological Sciences, 2004
- Antiviral chemotherapeutic agents against respiratory virusesCurrent Opinion in Pulmonary Medicine, 2004
- Global Surveillance, National Surveillance, and SARSEmerging Infectious Diseases, 2004
- Artesunate combinations for treatment of malaria: meta-analysisThe Lancet, 2004
- Virtual drug discovery and development for neglected diseases through public–private partnershipsNature Reviews Drug Discovery, 2003
- Enhanced: The Need for a Global HIV Vaccine EnterpriseScience, 2003
- Product R&D for neglected diseasesEMBO Reports, 2003
- Letters to the EditorsTropical Medicine & International Health, 2001
- Reaching Maturity — 25 Years of the TDRParasitology Today, 2000